Department of Nutritional Sciences and Obesity Research Cluster, Texas Tech University, Lubbock, Texas, USA.
Compr Physiol. 2017 Sep 12;7(4):1137-1150. doi: 10.1002/cphy.c160031.
The renin angiotensin system (RAS) is a major regulator of blood pressure, fluid, and electrolyte homeostasis. RAS precursor angiotensinogen (Agt) is cleaved into angiotensin I (Ang I) and II (Ang II) by renin and angiotensin converting enzyme (ACE), respectively. Major effects of Ang II, the main bioactive peptide of this system, is mediated by G protein coupled receptors, Angiotensin Type 1 (AGTR1, AT1R) and Type 2 (AGTR2, AT2R) receptors. Further, the discovery of additional RAS peptides such as Ang 1-7 generated by the action of another enzyme ACE2 identified novel functions of this complex system. In addition to the systemic RAS, several local RAS exist in organs such as the brain, kidney, pancreas, and adipose tissue. The expression and regulation of various components of RAS in adipose tissue prompted extensive research into the role of adipose RAS in metabolic diseases. Indeed, animal studies have shown that adipose-derived Agt contributes to circulating RAS, kidney, and blood pressure regulation. Further, mice overexpressing Agt have high blood pressure and increased adiposity characterized by inflammation, adipocyte hypertrophy, and insulin resistance, which can be reversed at least in part by RAS inhibition. These findings highlight the importance of this system in energy homeostasis, especially in the context of obesity. This overview article discusses the depot-specific functions of adipose RAS, genetic and pharmacological manipulations of RAS, and its applications to adipogenesis, thermogenesis, and overall energy homeostasis. © 2017 American Physiological Society. Compr Physiol 7:1137-1150, 2017.
肾素血管紧张素系统(RAS)是调节血压、体液和电解质平衡的主要系统。RAS 前体血管紧张素原(Agt)分别被肾素和血管紧张素转换酶(ACE)切割成血管紧张素 I(Ang I)和 Angiotensin II(Ang II)。该系统主要生物活性肽 Ang II 的主要作用是通过 G 蛋白偶联受体 Angiotensin Type 1(AGTR1,AT1R)和 Type 2(AGTR2,AT2R)受体介导。此外,通过另一种酶 ACE2 的作用发现了其他 RAS 肽,如 Ang 1-7,确定了该复杂系统的新功能。除了系统性 RAS 外,在大脑、肾脏、胰腺和脂肪组织等器官中还存在几种局部 RAS。脂肪组织中 RAS 的各种成分的表达和调节促使人们对脂肪 RAS 在代谢性疾病中的作用进行了广泛的研究。事实上,动物研究表明,脂肪组织来源的 Agt 有助于循环 RAS、肾脏和血压调节。此外,过表达 Agt 的小鼠具有高血压和肥胖特征,表现为炎症、脂肪细胞肥大和胰岛素抵抗,至少部分可以通过 RAS 抑制来逆转。这些发现强调了该系统在能量平衡中的重要性,尤其是在肥胖的背景下。本文综述了脂肪 RAS 的特定脂肪组织功能、RAS 的遗传和药理学操作及其在脂肪生成、生热和整体能量平衡中的应用。 2017 年美国生理学学会。综合生理学 7:1137-1150。